Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KQ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KQ.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.46ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.46ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.46ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.46NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.1.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.1.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.48ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.48ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.48ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.48NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.47.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.47.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.47.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.47.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.7.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.7.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.7.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.7.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.8.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.8.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.8.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.8.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GK.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-6672.85US
XCMORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XCMENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCMENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XCMNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HN.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HN.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HN.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HN.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.42.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.42.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.42.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.42.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17914.1US
HN.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-802.098France
HN.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HN.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HN.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-6672.85US
DV.7.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used